Home | Medical-Newswire.Com:
(Medical-NewsWire.com, November 14, 2017 ) According to the report Biosimilars Market, published by Market Data Forecast, the Global market is projected to reach USD 30.12 billion by 2022, at a CAGR of 36% from 2017 to 2022.
Biosimilars Industry are biological medical product which is an alike copy of original product produced by another company. Biosimilars have molecular complexity unlike small molecule generic drugs.
Get a comprehensive overview of the Biosimilars Market: http://www.marketdataforecast.com/market-reports/global-biosimilars-market-1142/
Biosimilars Market: Drivers & Restraints
Increasing geriatric population, growing demand for biosimilars and increasing incidence of diabetes and chronic disorders are the primary factors driving the growth of the market. Also increasing initiatives by government is expected to boost the market.
However, complexities associated with the production of biosimilars is a major factor hampering the growth of the market.
Get accurate market forecast and analysis on the Biosimilars Market. Request a sample to stay up-to-date on the main trends affecting this market: http://www.marketdataforecast.com/market-reports/global-biosimilars-market-1142/request-sample
Biosimilars Market: Segmentation
• Human Growth Hormones
• Granulocyte Colony-stimulating Factor (G-CSF)
• Recombinant Glycosylated Proteins
• Monoclonal Antibodies
• Recombinant Peptides
• Mass Spectroscopy
• Monoclonal Antibody Technology
• Recombinant DNA Technology
• Nuclear magnetic resonance (NMR) technology
• Oncology diseases
• Blood disorders
• Growth hormone deficiencies
• Chronic and autoimmune diseases
• North America
o United States
o South Korea
• Latin America
o Rest of Latin America
• Middle East & Africa
From simple data collation through secondary and primary research to ad-hoc research requests relating to specific information, we provide our services via customization. Get customization at http://www.marketdataforecast.com/market-reports/global-biosimilars-market-1142/customize-report
Biosimilars Market: Overview
In 2017, the Recombinant Non-glycosylated Proteins is expected to have the largest share of the market. Rising incidence of diabetes and cost-effectiveness are some factors that have boosted this category. In 2017 Oncology is anticipated to have fastest growth.
The Biosimilars Market is dominated by North America in 2017. North America was followed next in line by Europe and Asia Pacific. Asia Pacific is expected to witness significant growth owing to advancement in technologies, rising disposable income and growing economy.
Biosimilars Market: Key Players
The Biosimilars market is highly competitive with a large number of players. Some of the major Companies are Novartis (Sandoz), Teva Pharmaceutical Industries Ltd., Synthon Pharmaceuticals, Inc., and LG Life Sciences. Other companies operating in this market are Celltrion, Merck Serono (Merck Group), Biogen idec, Inc., Biocon, Hospira, and Genentech (Roche Group).
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options.
For more information, kindly visit, www.marketdataforecast.com
Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Market Data Forecast